English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new study by researchers at University of Limerick in Ireland and at Iowa State University has demonstrated the impact resistance exercise training can have in the treatment of anxiety and depressive symptoms.
Tag: Depression and Anxiety
Psilocybin – a promising therapy for treatment-resistant depression?
A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use.
Atopic dermatitis associated with schizophrenia, schizoaffective disorder
Atopic dermatitis (AD) is a chronic, inflammatory skin disorder that has well-established associations with depression and anxiety. A new Yale School of Medicine study finds AD is also associated with increased risk for schizophrenia and shizoaffective disorder. Schizophrenia is a…
Having dementia and reduction in social participation are associated with increased depression and anxiety during the COVID-19 pandemic
An increased risk of depression and anxiety among US older adults with dementia and poor activity participation has been demonstrated through an analysis of data from the National Health and Aging Trends Study (NHATS), a nationally representative population-based study.
Recognizing signs of depression in teens as we head into a difficult winter
As National Depression and Mental Health Screening Month comes to a close, and health officials warn of a difficult pandemic winter ahead, it’s important for parents to know how to identify symptoms of depression in their teenagers — and what…
A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor
For the first time, scientists at UNC-Chapel Hill and Stanford solved the high-resolution structure of psychedelic drugs bound to the 5-HT2A serotonin receptor, a major step toward understanding how the drugs cause such wild effects and how they might be better used to treat psychiatric conditions.
McLean Hospital Webinar Series: Shining A Light On OCD
Dr. Elizabeth McIngvale Helps Navigate the Challenges of OCD September 10 @ 11am EST Obsessive compulsive disorder (OCD) has no one-size-fits-all approach to treatment. As a clinician, you may find yourself in challenging situations regarding diagnoses and the need for…
Mental Health Experts Available to Discuss Increased Mental Health Needs Due to COVID-19
Media Advisory WHAT: Recent data released by the CDC indicates that COVID-19 has contributed to an increase in the number of young adults, minorities, essential workers, and unpaid caregivers reporting symptoms of anxiety and depression. This is not completely unexpected.…
Older adults with existing depression show resilience during the pandemic
Study finds that older adults with depression are showing resilience during the COVID-19 pandemic.
Roth Leads $26.9 Million Project to Create Better Psychiatric Medications
Funded by the Defense Advanced Research Projects Agency, a team of internationally acclaimed researchers led by UNC School of Medicine’s Bryan L. Roth, MD, PhD, aims to create new medications to effectively and rapidly treat depression, anxiety, and substance abuse without major side effects.